NeuroDerm Company Profile (NASDAQ:NDRM)

About NeuroDerm

NeuroDerm logoNeuroDerm Ltd. is a clinical-stage pharmaceutical company. The Company is engaged in developing treatments for central nervous system (CNS) disorders, primarily Parkinson's disease, as well as other CNS diseases. The Company is developing ND0612H for the treatment of patients suffering from severe Parkinson's disease; ND0612L for the treatment of patients at the moderate stage of Parkinson's disease that can no longer control motor complications with oral levodopa, and ND0680 for the treatment of a small subset of severe Parkinson's disease patients, whose symptoms have advanced to a severe stage, requiring even higher doses of LD/CD than ND0612H is designed to provide. The Company has also designed ND0701, an apomorphine-based product candidate that offers an alternative to the continuously administered apomorphine product, and ND0801, to treat cognition disorders associated with CNS diseases, such as ADD/ADHD, Alzheimer's disease and schizophrenia.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Biotechnology
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: NDRM
  • CUSIP:
Key Metrics:
  • Previous Close: $17.38
  • 50 Day Moving Average: $17.57
  • 200 Day Moving Average: $16.01
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -9.15
  • P/E Growth: 0.00
  • Market Cap: $375.56M
  • Outstanding Shares: 21,609,000
  • Beta: 0.98
Additional Links:
Companies Related to NeuroDerm:

Analyst Ratings

Consensus Ratings for NeuroDerm (NASDAQ:NDRM) (?)
Ratings Breakdown: 3 Buy Ratings
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $26.00 (49.60% upside)

Analysts' Ratings History for NeuroDerm (NASDAQ:NDRM)
Show:
DateFirmActionRatingPrice TargetDetails
5/29/2016Roth CapitalReiterated RatingBuyView Rating Details
4/2/2016Oppenheimer Holdings Inc.Initiated CoverageBuyView Rating Details
11/10/2015Raymond James Financial Inc.Initiated CoverageOutperform$28.00View Rating Details
8/14/2015Jefferies GroupReiterated RatingBuy$28.00View Rating Details
12/9/2014Cowen and CompanyInitiated CoverageOutperformView Rating Details
(Data available from 8/24/2014 forward)

Earnings

Earnings History for NeuroDerm (NASDAQ:NDRM)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/25/2016ListenView Earnings Details
5/26/2016Q1($0.35)($0.25)ViewListenView Earnings Details
3/31/2016Q4($0.29)$0.31ViewListenView Earnings Details
11/11/2015Q315($0.34)($0.49)ViewListenView Earnings Details
8/6/2015Q215($0.20)($0.34)ViewListenView Earnings Details
5/27/2015Q115($0.28)($0.09)ViewListenView Earnings Details
4/2/2015($0.35)($2.55)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for NeuroDerm (NASDAQ:NDRM)
Current Year EPS Consensus Estimate: $-1.54 EPS
Next Year EPS Consensus Estimate: $-1.9 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.29)($0.29)($0.29)
Q2 20162($0.40)($0.34)($0.37)
Q3 20162($0.40)($0.36)($0.38)
Q4 20161($0.37)($0.37)($0.37)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for NeuroDerm (NASDAQ:NDRM)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for NeuroDerm (NASDAQ:NDRM)
No insider trades for this company have been tracked by MarketBeat.com

Headlines

Latest Headlines for NeuroDerm (NASDAQ:NDRM)
DateHeadline
stocksdaily.net logoCan NeuroDerm Ltd. (NASDAQ:NDRM) Meet Analysts Expectations? - Stocks Daily (NASDAQ:NDRM)
www.stocksdaily.net - August 21 at 10:33 AM
baystreet.ca logoDurable Goods, Wholesale Trade, on Next Week's Docket - Baystreet.ca (NASDAQ:NDRM)
www.baystreet.ca - August 19 at 6:21 PM
finance.yahoo.com logoNeuroDerm to Host Second Quarter 2016 Financial Results Conference Call on August 25, 2016 (NASDAQ:NDRM)
finance.yahoo.com - August 11 at 9:37 AM
kcregister.com logoBest Stocks: Vale S.A. (NYSE:VALE), NeuroDerm Ltd. (NASDAQ:NDRM), Luminex Corporation (NASDAQ:LMNX ... - KC Register (NASDAQ:NDRM)
www.kcregister.com - August 2 at 6:42 PM
kcregister.com logoStock Runners: NeuroDerm Ltd. (NASDAQ:NDRM), The Walt Disney Company (NYSE:DIS), MGIC Investment (NYSE ... - KC Register (NASDAQ:NDRM)
www.kcregister.com - July 28 at 9:38 AM
finance.yahoo.com logo7:04 am NeuroDerm announces the USPTO has issued a patent related to its ND0701 program (NASDAQ:NDRM)
finance.yahoo.com - July 27 at 7:04 AM
finance.yahoo.com logoNeuroDerm Announces Issuance of a New U.S. Patent for Aqueous Apomorphine Covering Concentrated Subcutaneously Delivered Pharmaceutical Compositions (NASDAQ:NDRM)
finance.yahoo.com - July 27 at 7:00 AM
benzinga.com logoNeuroDerm Announces Start of Bioequivalence Trial... (NASDAQ:NDRM)
www.benzinga.com - July 26 at 6:42 PM
finance.yahoo.com logoNeuroDerm Announces Start of Bioequivalence Trial in Healthy Volunteers of ND0701, a New Continuous Subcutaneously Delivered Apomorphine Product Candidate for the Treatment of Advanced Parkinson’s Disease (NASDAQ:NDRM)
finance.yahoo.com - July 26 at 8:08 AM
News IconEquity Roundup: Stock Performance Focus on NeuroDerm Ltd. (NASDAQ:NDRM) - Press Telegraph (NASDAQ:NDRM)
presstelegraph.com - July 23 at 10:17 AM
News IconNeuroderm Limited Ord (NASDAQ:NDRM) Short Interest Decreased By 0.85% - Consumer Eagle (NASDAQ:NDRM)
www.consumereagle.com - July 21 at 6:42 PM
News IconInvestor Update: Earnings and Target Price Recap on NeuroDerm Ltd. (NASDAQ:NDRM) - Press Telegraph (NASDAQ:NDRM)
presstelegraph.com - July 21 at 6:42 PM
News IconNeuroDerm Ltd. (NASDAQ:NDRM) Wall Street Analyst Recommendation Outlook - TGP (NASDAQ:NDRM)
telanaganapress.com - July 18 at 6:32 PM
News IconNeuroderm Ltd Formed a Bullish Inverse H&S Pattern, Could Be One of The Best Performers Soon - Press Telegraph (NASDAQ:NDRM)
presstelegraph.com - July 18 at 11:44 AM
news.cmlviz.com logoNeuroDerm Ltd. Stock Momentum at Critical Inflection Point - CML News (NASDAQ:NDRM)
news.cmlviz.com - July 15 at 11:13 AM
News IconNeuroDerm Ltd. (NASDAQ:NDRM) Earnings Concentration and Analyst Target Watch - Engelwood Daily (NASDAQ:NDRM)
www.engelwooddaily.com - July 15 at 11:13 AM
News IconHow Many Neuroderm Ltd (NASDAQ:NDRM)'s Analysts Are Bearish? - Consumer Eagle (NASDAQ:NDRM)
www.consumereagle.com - July 12 at 6:40 PM
News IconWall Street Ratings and Target Price Views on NeuroDerm Ltd. (NASDAQ:NDRM) - Telanagana Press (NASDAQ:NDRM)
telanaganapress.com - July 11 at 11:02 AM
streetinsider.com logoNeuroDerm (NDRM) Names Tami Yardeni as COO - StreetInsider.com (NASDAQ:NDRM)
www.streetinsider.com - July 7 at 6:26 PM
News IconCan NeuroDerm Ltd. (NASDAQ:NDRM) Improve on the Earnings Front? - Engelwood Daily (NASDAQ:NDRM)
www.engelwooddaily.com - July 7 at 6:26 PM
streetinsider.com logoNeuroDerm (NDRM) Names Tami Yardeni as COO (NASDAQ:NDRM)
www.streetinsider.com - July 6 at 6:38 PM
finance.yahoo.com logoNeuroDerm Announces Additions to Management Team (NASDAQ:NDRM)
finance.yahoo.com - July 6 at 11:03 AM
finance.yahoo.com logoNeuroDerm to Present at the Cantor Fitzgerald Healthcare Conference on July 13 (NASDAQ:NDRM)
finance.yahoo.com - July 5 at 9:05 AM
News IconAre Analysts Bearish Neuroderm Ltd (NASDAQ:NDRM) After Last Week? - Press Telegraph (NASDAQ:NDRM)
presstelegraph.com - July 4 at 5:44 PM
rttnews.com logoIt's A Ten For Humira, AMPE Drubbed By PIVOT Data, CYNA Awaits Data In Q3 (NASDAQ:NDRM)
www.rttnews.com - July 1 at 9:14 AM
finance.yahoo.com logoNeuroDerm Announces Start of U.S. Patient Enrollment in Trial 006, a Phase II Trial of ND0612H for Advanced Parkinson’s Disease (NASDAQ:NDRM)
finance.yahoo.com - June 30 at 4:03 PM
finance.yahoo.com logoNeuroDerm Announces ND0612H Achieves Comparable Pharmacokinetics to DUODOPA® in Head-To-Head Pilot PK Comparison Trial (NASDAQ:NDRM)
finance.yahoo.com - June 28 at 11:16 AM
fiscalstandard.com logoNext Weeks Broker Price Targets For NeuroDerm Ltd. (NDRM) - Fiscal Standard (NASDAQ:NDRM)
www.fiscalstandard.com - June 27 at 6:18 PM
fiscalstandard.com logoBrokers Issue Average Price Target Of 27.50 On NeuroDerm Ltd. (NDRM) - Fiscal Standard (NASDAQ:NDRM)
www.fiscalstandard.com - June 25 at 5:58 PM
ftsenews.co.uk logoNew Broker Ratings For NeuroDerm Ltd. (NDRM) - FTSE News (NASDAQ:NDRM)
www.ftsenews.co.uk - June 25 at 5:58 PM
finance.yahoo.com logoNeuroDerm Added to Russell Global Index (NASDAQ:NDRM)
finance.yahoo.com - June 24 at 6:35 PM
news.cmlviz.com logoNeuroDerm Ltd. (NasdaqGM:NDRM) Stock Momentum at Critical Inflection Point - CML News (NASDAQ:NDRM)
news.cmlviz.com - June 23 at 6:54 PM
finance.yahoo.com logoNeuroDerm Presents Three Posters at the 20th International Congress of Parkinson’s Disease and Movement Disorders (NASDAQ:NDRM)
finance.yahoo.com - June 23 at 9:15 AM
fiscalstandard.com logoThis Weeks Broker Views For NeuroDerm Ltd. (NDRM) - Fiscal Standard (NASDAQ:NDRM)
www.fiscalstandard.com - June 20 at 8:02 AM
News IconNeuroDerm to Present Design of the First Clinical Efficacy Study of ND0612H and Other Clinical Data at the 20th International Congress of… (NASDAQ:NDRM)
forextv.com - June 16 at 10:39 AM
investors.com logoNeuroDerm to present trial data at Parkinson’s conference (NASDAQ:NDRM)
www.proactiveinvestors.com - June 16 at 10:39 AM
nasdaq.com logoNeuroDerm to Present Design of the First Clinical Efficacy Study of ND0612H and Other Clinical Data (NASDAQ:NDRM)
www.nasdaq.com - June 16 at 10:39 AM
finance.yahoo.com logoNeuroDerm to Present Design of the First Clinical Efficacy Study of ND0612H and Other Clinical Data at the 20th International Congress of Parkinson’s Disease and Movement Disorders (NASDAQ:NDRM)
finance.yahoo.com - June 16 at 7:00 AM
news.cmlviz.com logoNEURODERM LTD. (NASDAQ:NDRM) Financial Condition Compared to S&P 500 - CML News (NASDAQ:NDRM)
news.cmlviz.com - June 8 at 6:49 PM
zacks.com logoNeuroDerm (NDRM) Looks Good: Stock Adds 5.1% in Session (NASDAQ:NDRM)
www.zacks.com - June 7 at 9:03 AM
tradecalls.org logoRevenue Update on Neuroderm Ltd(NASDAQ:NDRM) - Trade Calls (NASDAQ:NDRM)
www.tradecalls.org - June 3 at 9:14 AM
News IconNeuroDerm Ltd. (NASDAQ:NDRM) Stock Update & Estimates - Stock Tick Tock (NASDAQ:NDRM)
www.stockticktock.com - June 2 at 6:46 PM
News IconStock Review and Earnings Check on NeuroDerm Ltd. (NASDAQ:NDRM) - HNN (NASDAQ:NDRM)
hintsnewsnetwork.com - June 2 at 6:46 PM
News IconBroker Watchlist: NeuroDerm Ltd. (NDRM) - Share Trading News (NASDAQ:NDRM)
www.sharetrading.news - June 2 at 6:46 PM
capitalcube.com logoNeuroDerm Ltd. :NDRM-US: Earnings Analysis: Q1, 2016 By the Numbers : June 2, 2016 (NASDAQ:NDRM)
www.capitalcube.com - June 2 at 12:59 PM
finance.yahoo.com logoNeuroDerm CEO to Present at Jefferies 2016 Healthcare Conference on June 7 (NASDAQ:NDRM)
finance.yahoo.com - May 31 at 2:11 PM
News IconShare Rating Focus on NeuroDerm Ltd. (NASDAQ:NDRM) - HNN (NASDAQ:NDRM)
hintsnewsnetwork.com - May 31 at 10:24 AM
News IconNeuroderm Ltd (NDRM) Rating Reiterated by Roth Capital - Let Me Know About This (NASDAQ:NDRM)
www.lmkat.com - May 30 at 11:03 PM
News IconNeuroDerm Ltd. (NDRM) Broker Price Targets For The Coming Week - Share Trading News (NASDAQ:NDRM)
www.sharetrading.news - May 30 at 12:40 PM
News IconEarnings Review and Stock Rundown for NeuroDerm Ltd. (NASDAQ:NDRM) - Wall Street Hints and News (NASDAQ:NDRM)
hintsnewsnetwork.com - May 28 at 11:02 AM

Social

NeuroDerm (NASDAQ:NDRM) Chart for Wednesday, August, 24, 2016


Last Updated on 8/24/2016 by MarketBeat.com Staff